2023 - Digital Endpoint Development for Alzheimer’s Disease: The Importance of Patients as Partners

Digital health technologies (DHTs) like smartphones and wearable sensors hold great promise to advance drug development and discovery in neurodegenerative diseases, particularly Alzheimer’s disease. Through objective, continuous, remote capture of real-world outcomes, DHTs have the capacity to measure the impact of novel treatments on how patients with Alzheimer’s disease feel and function in their real-world environments, which, in turn, enables the development of drugs that improve aspects of health that matter most to patients. A digital endpoint derived from DHTs thus gives deeper insight on a patient’s health.
To ensure the development of patient-centric endpoints in Alzheimer’s disease drug development, engaging patients as partners throughout the process of digital endpoint development is critical. In this webinar, the featured speakers bring together stakeholders representing the perspectives of pharma, technology developers, and most importantly, patients. The panel will discuss different approaches to patient engagement in digital health.
This webinar will close with a discussion between stakeholders focused on opportunities for promoting patient centricity in Alzheimer’s disease drug development and identify areas for improvement.
Register for this webinar today to understand how patient engagement can enhance digital endpoint development in Alzheimer’s disease clinical trials.